Estela Rodriguez, Associate Director of Community Outreach in Thoracic Oncology at the University of Miami’s Sylvester Comprehensive Cancer Center, shared on X:
“Obrigada, IASLC!
Excited to travel to São Paulo for Latin America Conference on Lung Cancer (LALCA) November 12-14 and share perspectives on incorporating ADCs and bispecific antibodies into lung cancer management.
- Scientific Session ES10.03
- November 13 | 11:45 AM
Looking forward to connecting with colleagues across Latin America!”
About LALCA 2026
The 2026 Latin America Conference on Lung Cancer (LALCA26) is the premier regional thoracic oncology meeting organized by the International Association for the Study of Lung Cancer (IASLC). For its 2026 edition, it is being held as a joint conference alongside the 16th Annual Meeting of the International Thymic Malignancy Interest Group (ITMIG).
Guided by the official theme ‘Connecting Latin America to the Forefront of Cancer Treatment, this joint event marks the first time the ITMIG community gathers in South America.
Scientific Focus and Themes
- Regional Priorities: Addressing specific challenges across Latin America, including biomarker testing access, early lung cancer screening, cancer control initiatives, and real-world implementation of targeted therapies and immunotherapies across diverse healthcare systems.
- Thymic and Mediastinal Malignancies: Through the ITMIG partnership, the program delivers comprehensive sessions on thymoma, thymic carcinoma, and rare mediastinal neoplasms, emphasizing surgical techniques, multidisciplinary tumor boards, and global registry data.
- Multidisciplinary Education: The scientific agenda covers invited lectures, parallel oral abstract presentations, poster discussions, and interactive workshops exploring resectable and metastatic non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), novel antibody-drug conjugates, and emerging resistance mechanisms.
- Inclusivity and Collaboration: Dedicated sessions highlight access to care, cancer control initiatives, and gender equity in thoracic oncology, fostering dialogue across international and regional borders.
The joint conference is co-chaired by Chul Kim and Alberto Dela Vega, bringing together medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists, pathologists, and researchers from across Latin America and around the world.
You can also read: IASLC Looking Forward to Welcoming the Thoracic Oncology Community at 2026 Latin America Conference